Hair-Loss Drug Impedes Prostate Cancer Detection in Middle-Aged Men

Armen Hareyan's picture

Researchers at Brigham and Women's Hospital (BWH) have found that the prostate specific antigen (PSA) cancer screening test is falsely lowered by a factor of two in middle-aged men who have taken Propecia, a hair-loss drug used by more than four million men worldwide, for one year.

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.